Conclusion
Cannabinoid research represents an exciting frontier in Alzheimer’s disease studies. Laboratory findings suggest that THC and related compounds can:
-
Promote amyloid-beta clearance
-
Activate the endocannabinoid system for neuroprotection
-
Reduce plaque formation and inflammation
-
Support oxidative stress management in neurons
Although clinical applications remain speculative, these insights provide a scientific rationale for further exploration. For families and researchers alike, this represents a promising avenue in the ongoing quest to combat neurodegenerative disorders.
